期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

分子影像学在帕金森病临床中的应用价值 被引量：2

原文传递
导出
摘要 单光子发射计算机断层扫描（SPECT）和正电子发射断层成像（PET）是近年来在帕金森病（PD）研究领域里进展最为迅速的分子成像技术，利用放射性示踪剂追踪PD患者脑内多巴胺代谢情况，通过对黑质纹状体多巴胺系统功能显像和定量反映PD病理改变。目前常用示踪剂包括多巴、多巴胺转运体（DAT）示踪剂和Ⅱ型囊泡单胺转运体（VMAT2）示踪剂等。
作者 刘振国
机构地区 上海交通大学医学院附属新华医院神经内科
出处 《中华神经科杂志》 CAS CSCD 北大核心 2010年第6期385-387,共3页 Chinese Journal of Neurology
关键词 帕金森病 分子影像学 单光子发射计算机断层扫描 放射性示踪剂 正电子发射断层成像 Ⅱ型囊泡单胺转运体 多巴胺代谢 价值
分类号 R742.5 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献24

  • 1Brooks DJ,Frey KA,Marek KL,et al.Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.Exp Neural,2003,184 Suppl 1:S68-79.
  • 2Dabwan V,Ma Y,Pillai V,et al.Comparative analysis of striatal FDOPA uptake in Parkinson' s disease:ratio method versus graphical approach.J Nucl Med,2002,43:1324-1330.
  • 3Eshuis SA,Jager PL,Maguire RP,et al.Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson' s disease and healthy controls.Eur J Nucl Med Mol Imaging,2009,36:454-462.
  • 4Malter W,Liepelt I,Berg D.Progression of Parkinson' s disease in the clinical phase:potential markers.Lancet Neural,2009,8:1158-1171.
  • 5Breit S,Reimold M,Reischl G,et al.11C d-threomethylphenidate PET in patients with Parkinson' s disease and essential tremor.J Neural Transm,2006,113:187-193.
  • 6Zijlmans J,Evans A,Fonts F,et al.123I FP-CIT spect study in vascular parkinsonism and Parkinson' s disease.Mov Disord,2007,22:1278-1285.
  • 7Stoffers D,Booij J,Bosscher L,et al.Early-stage 123I beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson' s disease.Eur J Nucl Med Mol Imaging,2005,32:689-695.
  • 8Seppi K,Scherfler C,Donnemiller E,et al.Topography of dopamine transporter availability in progressive supranuclear palsy:a voxelwise 123I beta-CIT SPECT analysis.Arch Neurol,2006,63:1154-1160.
  • 9Parkinson Study Group.A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism.Neurology,2000,55:1540-1547.
  • 10Benamer TS,Patterson J,Grosset DG.Accurate differentiation of parkinsonism and essential tremor using visual assessment of 123IFP-CIT SPECT imaging:the 123I-FP-CIT study group.Mov Disord,2000,15:503-510.

二级参考文献13

  • 1丁正同,王坚,蒋雨平,张振馨,谢慧君,项景德,刘兴党,杨莉芹,邬剑军,苏惠琳,陈正平,郭丽萍,刘楠.^(99m)Tc-TRODAT-1 SPECT多巴胺转运体显像在诊断早期帕金森病中的意义[J].中国临床神经科学,2005,13(1):1-5. 被引量：3
  • 2蒋雨平.多巴胺转运蛋白．史玉泉主编．神经病学新理论与新技术[M]．上海：上海科技教育出版社，1998：341—344
  • 3Frost JJ, Rosier A J, Reich SG, et al. Positron emission tomog Taphic imaging of the dopamine transporter with llc-win 35. 428 reveals marked declines in mild Parkinson's disease[J]. Ann Neurol, 1993, 34:423-431
  • 4Rinne JO, Bergman J, Ruottinen H, et al. Striatal uptake of a novel PET ligand, [^18F] beta-CET, is reduced in early Parkinson's disease[J]. Synapse, 1999,31:119-124
  • 5[4]Guttman M, Burkholder J, Kish SJ, et al. [^11]RTJ-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease:implications for the symptomatic threshold[J]. Neurology, 1997,48:1578-1583
  • 6Volkow ND, Ding Y-S, Fowler J S, et al. A new PET ligand for the dopamine transporter;, studies in the human brain. J Nucl Med, 1995.36:2162-2168
  • 7Kazumata K, Dhawan V, Chaly T, et al. Dopamine transparter imaging with fluorine-18-FPCIT and PET J[J]. Nucl Med, 1998, 39:1521-1530
  • 8Lund Kvist C Halldin C, Ginovart N, et al. [^18F]β-CIT-FP is superior to [^11C]β-CIT-FT for guantitation of the domamamine transpartor[J]. Nucl Med Biol, 1997, 24:621-627
  • 9彭湘闵，王坚，蒋雨平.帕金森病症状轻重程度的常用分级评量表．刘道宽等主编．锥体外系疾病[M]．上海：上海科技出版社，2000：109-118
  • 10Benamer HTS, Patterson J, Grasset DG. Accurate differentiation of parkinsonism and essential tremor using visual assenssment of [^123I]-FP-CIT SPECT inmging:. The [^123I]-FP-CIT study group [J]. Mov Disord, 2000,15:503-510

共引文献3

同被引文献75

  • 1Mclntosh AR.Mapping cognition to the brain through neural interactions.Memory,1999,7:523-548.
  • 2Friston KJ.Functional and effective connectivity in neuroimaging:a synthesis.Hum Brain Mapp,1994,2:56-78.
  • 3Friston KJ,Harrison L,Penny W.Dynamic causal modeling.NeuroImage,2003,19:1273-1302.
  • 4Alexander GE,Moeller JR.Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders:a principal component approach to modeling brain function in disease.Hum Brain Mapp,1994,2:1-16.
  • 5Eidelberg D.Metabolic brain networks in neurodegenerative disorders:a functional imaging approach.Trends Neurosci,2009,32:548-557.
  • 6Eckert T,Laere KV,Tang C,et al.Quantification of Parkinson' s disease-related network expression with ECD SPECT.Eur J Nucl Med Mol Imaging,2007,34:496-501.
  • 7Helmich RC,Derikx LC,Bakker M,et al.Spatial remapping of cortico-striatal connectivity in Parkinson' s disease.Cereb Cortex,2010,20:1175-1186.
  • 8Kwak Y,Peltier S,Bohnen NI,et al.Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson' s disease.Front Syst Neurosci,2010,4:1-25.
  • 9Rowe J,Stephan KE,Friston K J,et al.Attention to action in Parkinson' s disease:impaired effective connectivity among frontal cortical regions.Brain,2002,125:276-289.
  • 10McIntosh AR,Gonzalez-Lima F.Structual equation modeling and its application to network analysis in functional brain imaing.Hum Brain Mapp,1994,2:2-22.

引证文献2

二级引证文献10

中华神经科杂志
2010年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部